AR061769A1 - COMPOSITION FOR SKIN TREATMENT - Google Patents
COMPOSITION FOR SKIN TREATMENTInfo
- Publication number
- AR061769A1 AR061769A1 ARP070102946A ARP070102946A AR061769A1 AR 061769 A1 AR061769 A1 AR 061769A1 AR P070102946 A ARP070102946 A AR P070102946A AR P070102946 A ARP070102946 A AR P070102946A AR 061769 A1 AR061769 A1 AR 061769A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- skin treatment
- cephalopods
- liquid
- skin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 241000238366 Cephalopoda Species 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000010195 Onychomycosis Diseases 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000024386 fungal infectious disease Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 201000005882 tinea unguium Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composicion que comprende líquido natural de la bolsa de tinta de los cefalopodos y opcionalmente componentes adicionales de cefalopodos, el uso de dicho líquido para preparar un fármaco para el tratamiento de la micosis, preferiblemente onicomicosis y otras composiciones patologicas de la piel, y al uso de tal composicion como composicion cosmética .Composition comprising natural liquid from the ink bag of the cephalopods and optionally additional components of cephalopods, the use of said liquid to prepare a drug for the treatment of mycosis, preferably onychomycosis and other pathological compositions of the skin, and the use of such composition as cosmetic composition.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06013588 | 2006-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR061769A1 true AR061769A1 (en) | 2008-09-17 |
Family
ID=37309104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070102946A AR061769A1 (en) | 2006-06-30 | 2007-06-29 | COMPOSITION FOR SKIN TREATMENT |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR061769A1 (en) |
CL (1) | CL2007001929A1 (en) |
TW (1) | TW200822932A (en) |
WO (1) | WO2008000454A2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2945054B2 (en) * | 1990-03-03 | 1999-09-06 | 三省製薬株式会社 | External preparation for skin |
JPH0640932A (en) * | 1992-05-25 | 1994-02-15 | Eiko Hatakeyama | Protecting agent for hair of head |
CN1185964C (en) * | 2002-08-14 | 2005-01-26 | 王山 | Pure aquatic animal meat ham sausage or western type ham containing fish meat and preparation method |
-
2007
- 2007-06-27 WO PCT/EP2007/005674 patent/WO2008000454A2/en active Application Filing
- 2007-06-28 TW TW096123441A patent/TW200822932A/en unknown
- 2007-06-29 AR ARP070102946A patent/AR061769A1/en not_active Application Discontinuation
- 2007-06-29 CL CL2007001929A patent/CL2007001929A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008000454A8 (en) | 2008-09-25 |
WO2008000454A2 (en) | 2008-01-03 |
CL2007001929A1 (en) | 2009-01-23 |
WO2008000454A3 (en) | 2008-02-28 |
TW200822932A (en) | 2008-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP067093A (en) | SULFAMATE AND SULFAMIDE DERIVATIVES FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS | |
GT201400136A (en) | COMPOUNDS AND METHODS OF BENZALDEHYDE SUBSTITUTED FOR USE IN INCREASING OXYGENATION OF FABRICS | |
CO6430467A2 (en) | USEFUL PEPTIDES IN THE TREATMENT AND / OR CARE OF SKIN AND / OR HAIR AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | |
UY31456A1 (en) | DERIVATIVES OF 2-PIRAZINONA AS INHIBITORS OF THE ELASTASA DE LOS NEUTROFILOS | |
CR20110100A (en) | NEW DERIVATIVES OF SULFAMIDE REPLACED | |
GT200800250A (en) | ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS | |
AR047928A1 (en) | TETRAHYDROPIRIDOINDOL DERIVATIVES | |
CL2009000349A1 (en) | Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease. | |
ECSP077275A (en) | NOVEDOSOS DERIVED FROM HETEROARILSULFAMIDA BENZOFUSIONADOS USEFUL AS ANTICONVULSIVE AGENTS | |
CO6290622A2 (en) | COMPOSITIONS OF ANTITRANSPIRANT ASSETS WITH A SEC CHROMATOGRAM PRESENTING A HIGH INTENSITY OF PICO 4 SEC TO REDUCE TRANSPIRATION | |
CL2007002971A1 (en) | COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS. | |
DOP2011000264A (en) | AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY | |
CL2009001484A1 (en) | Glycinate salt of metformin; pharmaceutical composition comprising the salt; and its use to treat hyperglycemia. | |
UY30215A1 (en) | CHROMANOL DERIVATIVES REPLACED, PROCEDURES FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
UY31922A (en) | COMPOUNDS | |
CL2009000309A1 (en) | Aromatic fluoroglycoside derivatives, pharmaceutical composition containing these compounds, procedure to prepare it and its use in the treatment of type 1 and type 2 diabetes. | |
CL2011002675A1 (en) | Use of compounds derived from 9-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl-methyl nitrate or sulfate to reduce intraocular pressure; ophthalmic pharmaceutical composition comprising the compounds; and ophthalmic formulation of topical use that includes them. | |
UY31403A1 (en) | "NOVEDOUS DERIVATIVES OF ({((3-Methylphenyl) -2H-TETRAZOL-5-IL) -ETOXI} -4H-1,2,4-TRIAZOL-3-IL), PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND MEDICAL USE OF THE SAME" . | |
UY30087A1 (en) | PIPERAZINAS AND PIPERIDINAS AS POTENTIALS OF MGLUR5 | |
CL2007002970A1 (en) | COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS. | |
RU2014130012A (en) | MALVA NEGLECTA EXTRACT COMPOSITIONS | |
CL2007003643A1 (en) | PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS. | |
CL2011002617A1 (en) | Compounds derived from 2,5-disubstituted arylsulfonamides, ccr3 receptor modulators; pharmaceutical composition that includes them; and use of the compound or composition to prevent and / or treat an inflammatory or immunoregulatory disorder such as asthma, rhinitis, hiv, Alzheimer's disease, among others. | |
CL2012003265A1 (en) | Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide. | |
BRPI0815455C1 (en) | n-phenylacetamide derivative compounds, pharmaceutical composition, cosmetic composition, cosmetic use of a composition, and uses of a compound thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |